Skip to content
10-Q

Quarterly Report

Immune Design Corp.

0001437786-18-000059

← back to feed
Filed
Aug 1, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Jul 30, 2018 48.16M sh
Capex Q2 2018 · Jun 30, 2018 $243K
Capex Q2 2018 · Jun 30, 2017 $261K
Operating Cash Flow Q2 2018 · Jun 30, 2018 −$27.3M
Operating Cash Flow restated Q2 2018 · Jun 30, 2017 −$19.84M
Short Term Investments Q2 2018 · Jun 30, 2018 $46.8M
Short Term Investments Q2 2018 · Dec 31, 2017 $68.65M
Cash And Equivalents Q2 2018 · Jun 30, 2018 $73.43M
Cash And Equivalents Q2 2018 · Dec 31, 2017 $72.45M
Cash And Equivalents Q2 2018 · Jun 30, 2017 $35.31M
Stockholders Equity Q2 2018 · Jun 30, 2018 $116.72M
Stockholders Equity Q2 2018 · Dec 31, 2017 $139.21M
Current Liabilities Q2 2018 · Jun 30, 2018 $7.9M
Current Liabilities Q2 2018 · Dec 31, 2017 $14.52M
Current Assets Q2 2018 · Jun 30, 2018 $123.98M
Current Assets Q2 2018 · Dec 31, 2017 $153.14M
Total Assets Q2 2018 · Jun 30, 2018 $124.73M
Total Assets Q2 2018 · Dec 31, 2017 $153.83M
Sga Expense Q2 2018 · Jun 30, 2018 $4.01M
Sga Expense Q2 2018 · Jun 30, 2018 $8M
Sga Expense Q2 2018 · Jun 30, 2017 $3.89M
Sga Expense Q2 2018 · Jun 30, 2017 $8.02M
Rd Expense Q2 2018 · Jun 30, 2018 $11M
Rd Expense Q2 2018 · Jun 30, 2018 $21.31M
Rd Expense Q2 2018 · Jun 30, 2017 $10.86M
Rd Expense Q2 2018 · Jun 30, 2017 $24.9M
Net Income Q2 2018 · Jun 30, 2018 −$27.11M
Net Income Q2 2018 · Jun 30, 2017 −$26.47M
Operating Income Q2 2018 · Jun 30, 2018 −$14.39M
Operating Income Q2 2018 · Jun 30, 2018 −$28.2M
Operating Income Q2 2018 · Jun 30, 2017 −$14.04M
Operating Income Q2 2018 · Jun 30, 2017 −$26.79M